Luvometinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Luvometinib, covering 2026-01-27 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis [NA]